These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 16538414)

  • 41. Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit?
    Park SS; Park JM; Kim JH; Kim WB; Lee J; Kim SJ; Kim CS; Mok YJ
    J Surg Oncol; 2006 Jul; 94(1):16-20. PubMed ID: 16788938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morbidity after D2 and D3 gastrectomy for node-positive gastric carcinoma.
    Adachi Y; Mimori K; Mori M; Maehara Y; Sugimachi K
    J Am Coll Surg; 1997 Mar; 184(3):240-4. PubMed ID: 9060918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapeutic effects of transabdominal radical total gastrectomy on cardiac cancer: analysis of 56 cases].
    Wu T; Wan YL; Rong L; Pan YS; Wang X; Liu YC
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1474-7. PubMed ID: 17785085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase-II clinical trial of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for gastric cancer patients.
    Lee JH; Kim YW; Ryu KW; Lee JR; Kim CG; Choi IJ; Kook MC; Nam BH; Bae JM
    Ann Surg Oncol; 2007 Nov; 14(11):3148-53. PubMed ID: 17705092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Relationship between serosal invasion types and lymph node metastasis after total gastrectomy in gastric cancer and its significance in selection of rational dissection].
    Zhu HT; Zhao YL; Wu YF
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):474-7. PubMed ID: 19950563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
    Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Szczepanik A;
    Am J Surg; 2007 Jan; 193(1):10-5. PubMed ID: 17188080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer.
    Cheong O; Kim BS; Yook JH; Oh ST; Park YK; Ryu SY
    J Surg Oncol; 2008 Dec; 98(7):500-4. PubMed ID: 18770520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effectiveness of extended lymph node dissection for gastric cancer performed in Costa Rica under the supervision of a Japanese surgeon: a comparison with surgical results in Japan.
    Sasagawa T; Solano H; Vega W; Mena F
    Am J Surg; 2008 Jan; 195(1):53-60. PubMed ID: 18082543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcomes and survival after laparoscopic gastrectomy for adenocarcinoma. Analysis on 65 patients operated on by conventional or robot-assisted minimal access procedures.
    Pugliese R; Maggioni D; Sansonna F; Ferrari GC; Forgione A; Costanzi A; Magistro C; Pauna J; Di Lernia S; Citterio D; Brambilla C
    Eur J Surg Oncol; 2009 Mar; 35(3):281-8. PubMed ID: 18342480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
    Le A; Berger D; Lau M; El-Serag HB
    Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Appropriate gastric resection with lymph node dissection for early gastric cancer.
    Borie F; Plaisant N; Millat B; Hay JM; Fagniez PL;
    Ann Surg Oncol; 2004 May; 11(5):512-7. PubMed ID: 15078634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prophylactic lymph node dissection for early gastric cancer invading submucosa.
    Ikeda Y; Saku M; Kawanaka H; Nonaka M; Yoshida K; Maehara Y; Sugimachi K
    Hepatogastroenterology; 2004; 51(57):887-90. PubMed ID: 15143940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery.
    Lee JH; Ryu KW; Lee JH; Park SR; Kim CG; Kook MC; Nam BH; Kim YW; Bae JM
    Ann Surg Oncol; 2006 Sep; 13(9):1175-81. PubMed ID: 16947008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement.
    Kunisaki C; Shimada H; Yamaoka H; Takahashi M; Ookubo K; Akiyama H; Nomura M; Moriwaki Y
    Hepatogastroenterology; 2000; 47(32):586-9. PubMed ID: 10791244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effectiveness of para-aortic lymph node dissection for advanced gastric cancer].
    Zhan WH; He YL; Zheng ZQ; Peng JS; Cai SR; Ma JP
    Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):375-8. PubMed ID: 12892595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Laparoscopic pancreas- and spleen-preserving D2 lymph node dissection in advanced (cT2) upper-third gastric cancer.
    Hur H; Jeon HM; Kim W
    J Surg Oncol; 2008 Feb; 97(2):169-72. PubMed ID: 18095269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Stage-adapted radical principles in gastric carcinoma].
    Verreet PR
    Praxis (Bern 1994); 1998 Mar; 87(13):447-50. PubMed ID: 9584570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
    Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
    J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The role of superextended lymphadenectomy (D4) in gastric cancer].
    Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
    Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.
    Degiuli M; Sasako M; Calgaro M; Garino M; Rebecchi F; Mineccia M; Scaglione D; Andreone D; Ponti A; Calvo F;
    Eur J Surg Oncol; 2004 Apr; 30(3):303-8. PubMed ID: 15028313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.